O-P'DDD THERAPY IN CUSHING'S SYNDROME AND IN OBESITY WITH CUSHINGOID CHANGES.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D001774:Blood Chemical Analysis; D050260:Carbohydrate Metabolism; D002648:Child; D003480:Cushing Syndrome; D003634:DDT; D003632:Dichlorodiphenyldichloroethane; D004358:Drug Therapy; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin; D008055:Lipids / Q000097:blood*; D009765:Obesity; D013960:Thyroid Function Tests; D014116:Toxicology; D014527:Uric Acid
D007328:Insulin; D008055:Lipids; D014527:Uric Acid; D000324:Adrenocorticotropic Hormone; D003634:DDT; D003632:Dichlorodiphenyldichloroethane
BLOOD CHEMICAL ANALYSIS; BLOOD LIPIDS; CARBOHYDRATE METABOLISM; CHILD; CORTICOTROPIN, THERAPEUTIC; CUSHING'S SYNDROME; DDT; DRUG THERAPY; GLUCOSE TOLERANCE TEST; INSULIN; OBESITY; PROTEIN-BOUND IODINE TEST; TOXICOLOGIC REPORT; URIC ACID